Coadministration of adenoviral vascular endothelial growth factor and angiopoietin-1 enhances vascularization and reduces ventricular remodeling in the infarcted myocardium of type 1 diabetic rats. [electronic resource]
Producer: 20100225Description: 51-60 p. digitalISSN:- 1939-327X
- Adenoviridae
- Angiopoietin-1 -- administration & dosage
- Animals
- Capillaries -- drug effects
- Diabetes Mellitus, Experimental -- complications
- Diabetic Angiopathies -- drug therapy
- Heart Ventricles -- drug effects
- Humans
- Male
- Microtubule-Associated Proteins -- drug effects
- Myocardial Infarction -- physiopathology
- Rats
- Receptor, TIE-2 -- drug effects
- Survivin
- Vascular Endothelial Growth Factor A -- administration & dosage
- Vascular Endothelial Growth Factor Receptor-2 -- drug effects
- Ventricular Remodeling -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.